Skip to content

To study the efficacy of Katakadi Anjana in the management of Dry Eye Syndrome

A Randomised Controlled Clinical Study to Evaluate the Efficacy of Katakadi Anjana and Carboxymethylcellulose Eye Drops in Dry Eye Syndrome - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059003
Enrollment
60
Registered
2023-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre, Nigdi, Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients showing minimum 3 signs and symptoms of dry eye syndrome like burning sensation, foreign body sensation, redness, blurring of vision, ocular fatigue, excessive blinking. 2. Patients fit for anjana karma

Exclusion criteria

Exclusion criteria: 1. Known case of any congenital anomalies of the eye. 2. Any acute infective condition of the eye. 3. Severe dry eye with corneal involvement

Design outcomes

Primary

MeasureTime frame
1. To evaluate the efficacy of Katakadi Anjana on both eyes in the dose of 2 mg in each eye in the management of dry eye syndrome for 7 days on the Tear Film Break Up Time (TBUT)test.Timepoint: 7 days of study with 2 follows on the 4th and 7th day

Secondary

MeasureTime frame
To study the adverse drug effects if anyTimepoint: 7 days of study with 2 follows on the 4th and 7th day

Countries

India

Contacts

Public ContactDr Payal Sayagaonkar

PDEAs College of Ayurved and Research Centre, Nigdi, Pune

drvirkarchandana@gmail.com9822199107

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026